Performance of a commercial assay for the diagnosis of influenza A (H1N1) infection in comparison to the centers for disease control and prevention protocol of real time RT-PCR;Evaluación del desempeño de un equipo comercial para el diagnóstico de influenza A (H1N1) en comparación con el protocolo de RT-PCR en tiempo real diseñado por los centres de control y preventión de enfer-medades (CDC)

Revista Argentina de Microbiologia

Volumn 44, Issue 1, 2012, Pages 26-29

  Barbás, María G ^a   Gallego, Sandra V ^a   Castro, Gonzalo M ^a   Baumeister, Elsa ^b   Kademian, Silvia ^a   de Leon, Juan ^a   Cudolá, Analía ^a  

^a Laboratorio Centraldel Ministerio de Saludde la Provincia de Córdoba   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Influenza; Pandemic; PCR

Indexed keywords

2009 H1N1 INFLUENZA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; IMMUNOASSAY; INTERMETHOD COMPARISON; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; ANALYTICAL EQUIPMENT; ARGENTINA; COMPARATIVE STUDY; EPIDEMIC; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; METHODOLOGY; NOSE CAVITY; PHARYNX; PUBLIC HEALTH SERVICE; REPRODUCIBILITY; UNITED STATES; VALIDATION STUDY; VIROLOGY;

CORE PROTEIN; H1N1 VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN; VIRUS RNA;

ARGENTINA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NASAL CAVITY; PHARYNX; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRAL CORE PROTEINS;

EID: 84863750077     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children Southern California. Morb Mortal Wkly Rep. 2009; 58: 400-402.
2. CDC protocol of real time RTPCR for swine influenza A (H1N1) [Online] http://www.who.int/csr/resources/ publications/swineflu/realtimeptpcr/en/
3. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of novel swine-origin influenza A (H1N1) virus in humans. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. N Engl J Med 2009; 360: 2605-2615.
4. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van K, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Espejo Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 1557-1561.
5. Influenza A/H1N1 detection set pre-mixed primers and hydrolysis probes for detection of influenza A matrix protein 2 and hemagglutinin H1 (Mexico) genes 2009. Cat.No. 05640393001.
6. Influenza A/H1N1 Detection Set Package Insert Version November 2009 premixed primers and hydrolysis probes for detection of 2009 H1N1 influenza A viral RNA in human samples using the Light Cycler®2.0 Instrument.
7. Lindstrom S, Klimov A, Cox N, Loftin L. Primer and probes for detection and discrimination of types and subtypes of influenza viruses by real-time RT-PCR. The Centers for Disease Control and Prevention Technologies Brochure, 2011, p49. Reference Number: I-007-05 Publication Number: WO/2007/09515. [Online] http://www.cdc.gov/osels/laboratory_science/tech_tran/doc/ June_2011_Brochure.pdf
8. Ministerio de Salud de la Repúblics Argentina, 2009. Alerta epidemiológico. [Online] http://www.msal.gov.ar/htm/site/alertaepidemiologico.asp
9. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44: 1084-1088.
10. Robinson JL, Lee BE, Patel J, Bastien N, Grimsrud K, Seal RF, King R, Marshall F, Li Y Swine influenza (H3N2) infection in a child and possible community transmission, Canada. Emerg Infect Dis 2007; 13: 1865-1870.
11. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009; 360: 2616-2625.
12. Wells DL, Hopfensperger DJ, Arden NH, Harmon MW, Davis JP, Tipple MA, Schonberger LB. Swine influenza virus infections: transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA 1991; 265: 478-481.
13. Wenzel J J, Panning M, Kaul KL, Mangold KA, Revell PA, Luna RA, Zepeda H, Perea L, Vazquez-Perez JA, Young S, Rodic-Polic B, Eickmann M, Drosten C, Jilg W, Reischl U. Analytical performance determination and clinical validation of the novel Roche Real Time Ready Influenza A/H1N1 detection set. J Clin Microbiol 2010; 48: 3088-3094.
14. World Health Organization. Human infection with new influenza A (H1N1) virus; Clinical observations from Mexico and other affected countries; May 2009. Wkly Epidemiol Rec 2009;84: 185-189.